IDO1 and neoplasm: Utilizing various cancer models, we have confirmed that our Salmonella typhimurium-based platform targeting IDO (shIDO-ST) is engulfed by tumor-infiltrating neutrophils, leading to hyperactivation of their cytotoxic activity and subsequent tumor regression [22,35].